Silvercrest Asset Management’s Myriad Genetics MYGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-183,206	Closed	-$5.25M	–	761
2019 Q3	$5.25M	Buy	+183,206	New	+$5.25M	0.04%	326